John E. Imhoff

John E. Imhoff appears in our data through filings on Guided Therapeutics Inc shares, published by SEC (Form 4). In total, 35 filings cover trades dated from 28 May 2009 to 17 January 2025.

On the market, this insider has only ever bought: 8 purchases, €567k in total. The amount is not disclosed for 5 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 7 share grants and 6 option exercises.

Half of the purchases are above €83k and half below.

The latest filing, published on 18 February 2025, reports a transaction in Guided Therapeutics Inc. The clock since the last published purchase (20 December 2024) now reads 673 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 17 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.